Concepedia

Peter Grobara

PG

Statistics

Publications

7

Citations

535

H-Index

7

Active since

1993

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (Netherlands)

Herlev Hospital

Onze Lieve Vrouwziekenhuis Hospital

University of Copenhagen

Peter Grobara is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, clinical pharmacology, and pharmacology.

Publications per year

1993–2017

7

Publications

7

Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study

B. Brueckmann, Nobuo Sasaki, Peter Grobara et al. · British Journal of Anaesthesia · 2015 · 215 citations · Full text

, , +8

[Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study].

Herwig Kollaritsch, Hasso Holst, Peter Grobara et al. · PubMed · 1993 · 123 citations

, , +17

Repeat dosing of rocuronium 1.2 mg kg−1 after reversal of neuromuscular block by sugammadex 4.0 mg kg−1 in anaesthetized healthy volunteers: a modelling-based pilot study

Guy Cammu, Pieter‐Jan de Kam, K Graeve et al. · British Journal of Anaesthesia · 2010 · 57 citations · Full text

, , +5

Deep Neuromuscular Blockade Improves Laparoscopic Surgical Conditions: A Randomized, Controlled Study

Jacob Rosenberg, W. Joseph Herring, Manfred Blobner et al. · Advances in Therapy · 2017 · 56 citations · Full text

, , +15

Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects

Pieter‐Jan de Kam, Peter Grobara, Marita Prohn et al. · International Journal of Clinical Pharmacology and Therapeutics · 2014 · 48 citations

, , +17

1–5 of 7